Drug
Cmp 002
Cmp 002: highest development phase Phase 1/2, developed by CAMP4 Therapeutics Corporation. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- CAMP4 Therapeutics Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| CMP-002 NCT07935135 | Phase 1/2 | Nervous System Disease |
Latest
No recent events.
Follow Cmp 002 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.